SUMMARIES OF THE FIRST CLINICAL
STUDIES
ON THE
ORAL CHELATION AND AGE-LESS FORMULA
Heavy metal urine analysis
were conducted on 14 patients, ages ranging from 29 to
73 and from a variety of different occupations, before
and after only one day's dose of the Oral Chelation and
Age-Less formulas. Omegatech, King James Medical Laboratory,
Inc., in Cleveland, Ohio, analyzed the urine samples.
The results showed significant
excretion of all six of the heavy metals most commonly
encountered and damaging to health. The following are
the average percentages of increase in the 14 patients'
heavy metal excretions after just one day on the formula:
Aluminum: 229%
Arsenic: 661%
Cadmium: 276%
Lead: 350%
Mercury: 773
Nickel: 9,439%
Buy Oral Chelation today
Hair analyses were conducted
on two patients both before Oral Chelation and after six
months on the program. After six months on the formula,
each showed a significant reduction of heavy metals. In
the case of a dentist who had high exposure to mercury,
the six-month hair analysis showed a decrease or a normal
reading in all heavy metals that were abnormally high
on the first hair analysis, except for mercury which was
higher. In the other case with a dental hygienist, the
six-month hair analysis showed a decrease or a normal
reading in all heavy metals that were abnormally high
on the first analysis, except for silver which went higher.
Heavy metals can be stored
deep in the tissues, brain, and nerve ganglion. When all
heavy metals except one decrease after chelation, we know
that this one was stored deep in the body tissue and is
finally being pulled out of this tissue and mobilized
for excretion. Thus, the higher readings are a positive
sign that chelation is under way. In individuals with
chronic or longstanding exposure to high amounts of heavy
metals, the hair analysis readings can remain high and
even go higher for a period of six to twelve months depending
on the amount of previous exposure.
Thermology is a diagnostic
imaging procedure based on measurements of heat emissions
from the body. Infrared sensing devices read the heat
signals and project the patterns of emission onto a computer
monitor. Cells emit heat in the course of energy conversion.
If there is a disturbance in the energy-conversion processes,
as occurs in the case of blocked or narrowed arteries,
the lessened heat emissions and reduced blood flow appear
as darker areas on the thermology scan. In this way, thermology
tracks the progressive deterioration of the flow of infrared
energy along atherosclerotic arteries and can be used
as early detection of heart disease.
The results of Dr. Hoekstra's
study revealed marked improvement in blood circulation
in all but one of the patients, as documented by the thermologic
images. Vascularization (improved blood flow) of the feet
increased by as much as 33%-significant improvements after
only a six-month trial.
Nancy Gardner Heaven, director
of the Foundation, states, "It appears that even
though the clients selected for this study had varying
complex heart conditions, all but one had an improvement
of at least a 20% increase in circulation, reducing the
level of stenosis (narrowing) of the vascular system.
I feel very good about recommending the use of this product
(Oral Chelation and Age-Less formulas) to my patients
with cardiovascular disease or a family history where
prevention is an issue."
Patient Reports on the Oral
Chelation Program
In Dr. Poul's (Extreme's Director of Research) private
practice, there are currently 85 patients with a variety
of health concerns who are taking the Oral Chelation and
Age-Less formulas. They report improvement in the following
conditions: headaches, cold hands or feet, skin problems,
and degenerative diseases such as diabetes, autoimmune
disorders, arthritis, and angina pains. They have also
experienced positive effects in symptoms and conditions
related to energy level, overall stamina, memory (forgetfulness),
ability to concentrate, circulation, blood pressure, cholesterol
and triglyceride levels, vision, respiration, and sexual
drive or stamina. Research has proven the benefits of
chelation for cardiovascular disease, heavy metal toxicity,
and other conditions.
SUMMARIES OF THE SECOND CLINICAL
STUDIES ON THE ORAL CHELATION AND AGE-LESS FORMULA
Heavy metal urine analyses were conducted on eleven (n=11)
patients both before and after a single dose of the Oral
Chelation and Age-Less Formula. Age ranges in this sample
were from 43 to 76, and individuals were from a variety
of occupations. The single Oral Chelation dose consisted
of the administration of six (6) capsules prior to sleep,
and the single dose Age-Less consisted of the administration
of six (6) caplets at the same time, prior to sleep. A
first urine sample was collected prior to the administration
of the Oral Chelation agents and a second urine sample
was collected after the administration of the Age-Less
agents the next day. Omegatech, King James Medical Laboratory
in Cleveland, OH. analyzed each of the urine samples from
the 11 patients. The results showed an increase in excretion
of seven of the most toxic heavy metals most commonly
encountered and damaging to health. The following are
average percentage increases in heavy metal excretion
in the 11 patients after just a single administration
of the Oral Chelation and Age-Less Formula:
Aluminum: 182%
Arsenic: 320%
Cadmium: 9%
Copper: 344%
Lead: 162%
Mercury: 229%
Nickel: 43%
Buy Oral Chelation today
Four patients had blood analyzed
to determine the difference in total blood cholesterol,
HDL cholesterol, LDL cholesterol, VLDL cholesterol, and
blood triglyceride levels before and after the Oral Chelation
protocol. Blood was drawn prior to the initiation of the
Oral Chelation protocol and again eight months later.
Each patient administered three (3) capsules of Oral Chelation
prior to sleep and three (3) caplets of Age-Less upon
waking for an eight-month time period. Unilab in San Jose,
CA analyzed the blood samples. The results show significant
reductions in total blood cholesterol and triglyceride
levels. The following are the average differences in blood
composition from the initiation (baseline) of the protocol
until its end at 8 months. Negative values indicate a
decrease in the respective constituent after the eight-month
time period. All values reported are in mg/dl.
Total Cholesterol: -32.5
Triglycerides: -71 HDL: -0.5
LDL: -24 VLDL: -8.05 HDL/Total Cholesterol: -0.82
The following are the average
changes in blood composition as percentages for the above
values:
Total Cholesterol: -16%
Triglycerides: -29%
HDL: -1% LDL:
-18% VLDL: -16% HDL/Total Cholesterol: -15%
All categories, except HDL
Cholesterol, significantly improved during this eight-month
period. Each of these patients had cardiac problems prior
to beginning our Oral Chelation eight-month protocol.
All had either received, or had recommended by their physician,
a form of cardiac surgery in an attempt to improve their
respective conditions.
A medical doctor in Alamo,
California, tested one of his patients who took the Oral
Chelation and Age-Less Formula with no other supplements
or medications. After only two months of this regimen,
blood tests showed significant reduction of triglycerides
and LDL cholesterol, and an increase in HDL cholesterol
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose,
treat, cure or prevent any disease.